The m6A Reader IGF2BP2 Drives Depressive-like Behaviors Through m6A-Dependent Repression of Astrocytic GLUT1 and Glucose Metabolism
International Journal of Molecular Sciences · 31.10.2026 · 27 (21) · 9803
DOI: 10.3390/ijms27219803 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 31.10.2026. Verfasst von Zijing Liu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences, School of Basic Medicine Peking Union Medical College, Beijing 100005, Chin…. Hauptthemen laut MEDLINE: Glucose Transporter Type 1, Glucose, Astrocytes, Major Depressive Disorder. Die Arbeit nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Chinese Academy of Medical Sciences & Peking Union Medical College, science and technology innovation 2030 major projects, STI2030-Major Projects.
Abstract (Originalsprache)
Major depressive disorder (MDD) is a severe psychiatric condition with complex etiology and limited therapeutic targets. In this study, we identify the m6A reader protein IGF2BP2 as a critical epigenetic regulator in depression. We demonstrate that IGF2BP2 expression is significantly upregulated in the hippocampus of both MDD patients and mice subjected to chronic unpredictable mild stress (CUMS). Further, hippocampal knockdown of Igf2bp2 ameliorated depressive-like behaviors in mice. Mechanistically, we demonstrated that the IGF2BP2 protein, specifically in astrocytes, binds to the mRNA of glucose transporter 1 (GLUT1) and regulates the expression of GLUT1 in an m6A-dependent manner, mainly by promoting its decay, leading to impaired astrocytic glucose uptake. Moreover, overexpression of Glut1 rescued both glucose metabolic deficits and depressive-like behaviors. Taken together, our findings reveal a previously unrecognized IGF2BP2-GLUT1 axis in the pathogenesis of depression and highlight its potential as a therapeutic target for antidepressant intervention.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences, School of Basic Medicine Peking Union Medical College, Beijing 100005, China.
- State Key Laboratory of Common Mechanism Research for Major Diseases, Beijing 100005, China.
- Department of Urology, Peking University First Hospital, Beijing 100034, China.
- Beijing Key Laboratory of Urogenital Diseases (Male) Molecular Diagnosis and Treatment Center, Beijing 100034, China.
- National Urological Cancer Center, Beijing 100034, China.
- State Key Laboratory of Complex, Severe, and Rare Diseases, Beijing 100005, China.
Förderung
- Chinese Academy of Medical Sciences & Peking Union Medical College
- science and technology innovation 2030 major projects
- STI2030-Major Projects
- CAMS Innovation Fund for Medical Sciences
Zitieren
APA
Liu, Z., Li, J., Meng, K., Su, Y., Zhang, Y., & Xiu, J. (2026). The m6A Reader IGF2BP2 Drives Depressive-like Behaviors Through m6A-Dependent Repression of Astrocytic GLUT1 and Glucose Metabolism. International Journal of Molecular Sciences, 27(21), 9803. https://doi.org/10.3390/ijms27219803
Vancouver
Liu Z, Li J, Meng K, Su Y, Zhang Y, Xiu J. The m6A Reader IGF2BP2 Drives Depressive-like Behaviors Through m6A-Dependent Repression of Astrocytic GLUT1 and Glucose Metabolism. International Journal of Molecular Sciences. 2026;27(21):9803. doi:10.3390/ijms27219803
BibTeX
@article{Liu2026,
author = {Liu, Zijing and Li, Jiayu and Meng, Kexin and Su, Yuwen and Zhang, Yaqun and Xiu, Jianbo},
title = {The m6A Reader IGF2BP2 Drives Depressive-like Behaviors Through m6A-Dependent Repression of Astrocytic GLUT1 and Glucose Metabolism},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {21},
pages = {9803},
doi = {10.3390/ijms27219803}
}
EUVIMED